Bank of Hawaii’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Bank of Hawaii's NVO Position: Q2 2026 in Review
Bank of Hawaii increased its Novo Nordisk (NVO) stake by 69% in Q2 2026, buying an estimated $245K and bringing the position to 14,016 shares worth $672K. The position accounts for 0.03% of the portfolio, ranked #163.
Bank of Hawaii first reported a position in NVO in Q1 2016 and has held it in 19 quarters since. The position peaked at $1.96M in Q1 2018. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Bank of Hawaii held 14,016 shares of Novo Nordisk worth $672K as of Q2 2026.
- Bank of Hawaii bought 5,703 Novo Nordisk shares in Q2 2026, an estimated $245K.
- Novo Nordisk made up 0.03% of Bank of Hawaii's portfolio in Q2 2026, its #163 holding.
- Bank of Hawaii first reported a position in Novo Nordisk in Q1 2016 and has held it in 19 quarters since.
- Bank of Hawaii's Novo Nordisk position peaked at $1.96M in Q1 2018.
- 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Bank of Hawaii's 13F filing for Q2 2026, filed 14 Aug 2026.